Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Assets (2016 - 2025)

Medifast (MED) has disclosed Assets for 16 consecutive years, with $248.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets fell 12.75% year-over-year to $248.0 million, compared with a TTM value of $248.0 million through Dec 2025, down 12.75%, and an annual FY2025 reading of $248.0 million, down 12.75% over the prior year.
  • Assets was $248.0 million for Q4 2025 at Medifast, down from $268.2 million in the prior quarter.
  • Across five years, Assets topped out at $421.4 million in Q1 2022 and bottomed at $248.0 million in Q4 2025.
  • Average Assets over 5 years is $318.6 million, with a median of $317.5 million recorded in 2022.
  • The sharpest move saw Assets surged 61.47% in 2021, then decreased 23.69% in 2023.
  • Year by year, Assets stood at $398.3 million in 2021, then dropped by 20.61% to $316.2 million in 2022, then decreased by 1.99% to $309.9 million in 2023, then dropped by 8.29% to $284.2 million in 2024, then fell by 12.75% to $248.0 million in 2025.
  • Business Quant data shows Assets for MED at $248.0 million in Q4 2025, $268.2 million in Q3 2025, and $269.3 million in Q2 2025.